Acquisition International - Issue 11 2022 7 As a company, Solitek has become known as a household name in the preformulation services industry. Nominally, its founders’ dedication to solid-state development in small molecule pharmaceuticals has secured this reputation, a touchstone from which it can expand into further preformulation, solid-state and crystallization services. With a dedication to helping its clients to resolve the challenges of operating in the modern world, it has delivered a variety of solutions, making itself an invaluable partner for its clients throughout their operations. Sep22472 olitek, a firm specialising in preformulation, solid-state and crystallization services, supports clients with programs from late discovery to early preclinical stages of development, and beyond to production, bringing the right experts to the right projects on a reliable basis. Solitek always invests in the right professionals and the best tools in order to find the blend of technologies and expertise that will best benefit its clients. The result is an experienced and profoundly effective team that boasts past work with other chemical developers. Such experienced and diligent people don’t pop up from nowhere, however. Thus, as well as hiring the best of the best, when it takes on a hire straight from the classroom, it enrols graduates in an in-depth training programme that teaches them the rigour of its standards, after which they are fully competent to participate with high value impact to a customer’s project. This not only gives the student in question a more solid foundation of practical learning for industry; it also betters the solid-state sector in the macro scale by bolstering the ranks of those specifically trained to excel within this field. Thriving on projects big S Best Novel Solid State Services Provider 2022 and small, it conducts large screening programmes and specific, smallscale problem solving alike, proud to show through this work that its staff are invigorated by challenge. Fundamentally, this aids it in reaching its goals for reducing drug development costs in the industry, optimising the physical properties of drugs entering clinical phases. Thus, this will reduce attrition rate and increase efficacy, saving time, money, and effort in the process which can all be redirected towards better and more practical things. Working with small and medium sized biotechnology businesses in general, it has been increasingly adding work with larger pharma companies into the mix; no matter the size of the client’s business or their requirements, it will always be determined to provide the best solution for the challenges in preformulation, solid-state and crystallization. With its staff being an important part of this process, its internal synergy is also something that is second to none. For each project, there is a team of scientists and a project manager, but in the wider scale, within that team there will be a myriad of different specialisms and academic backgrounds all working together to ensure that each angle and perspective is considered. Moreover, the commitment that each of its staff members has to the company and client, together with their backgrounds in medicinal chemistry, process development, and pharmaceutical production, sets it apart from its peers, together with a flexibility and agility that is unmatched by its larger competitors. In short: watch this space. Company: Solitek Contact: Victor Diaz Website: solitekpharma.com
RkJQdWJsaXNoZXIy NTY1MjM3